COMMUNIQUÉS West-GlobeNewswire

Idorsia successfully completes convertible bonds restructuring
27/08/2025
Ad hoc announcement pursuant to Art. 53 LR Allschwil, Switzerland – August 27, 2025 Idorsia Ltd (SIX: IDIA) settled the repurchase offer for its outstanding CHF 204 * million convertible bonds maturing in 2025 ( CB 2025 [...]
Vivoryon Therapeutics N.V. to Report H1 2025 Financial Results and Operational Progress on September 4, 2025
27/08/2025
Vivoryon Therapeutics N.V. to Report H1 2025 Financial Results and Operational Progress on September 4, 2025 Halle (Saale) / Munich, Germany, August 27 , 2025 - Vivoryon Therapeutics N.V. (Euronext Amsterdam: VVY; [...]
BioVersys Receives EMA Orphan Designation for the Combination of Alpibectir and Ethionamide for the Treatment of Tuberculosis
27/08/2025
Ad hoc announcement pursuant to Art. 53 LR BASEL, Switzerland, Aug. 27, 2025 (GLOBE NEWSWIRE) -- Orphan designation is granted to drug candidates addressing life-threatening or chronically debilitating diseases [...]
Junshi Biosciences Announces 2025 Interim Financial Results and Provides Corporate Updates
27/08/2025
SHANGHAI, Aug. 26, 2025 (GLOBE NEWSWIRE) -- Shanghai Junshi Biosciences Co., Ltd (“Junshi Biosciences,” HKEX: 1877; SSE: 688180), a leading innovation-driven biopharmaceutical company dedicated to the discovery, [...]
Immuron partners with InvestorHub
27/08/2025
MELBOURNE, Australia, Aug. 26, 2025 (GLOBE NEWSWIRE) -- Immuron Limited (ASX: IMC; NASDAQ: IMRN) advises it has entered into a partnership with InvestorHub, a direct-to-investor engagement software company that provides [...]
SI-BONE to Present at Morgan Stanley 23rd Global Healthcare Conference on September 9, 2025
26/08/2025
SANTA CLARA, Calif., Aug. 26, 2025 (GLOBE NEWSWIRE) -- SI-BONE, Inc. (Nasdaq: SIBN), a medical device company dedicated to solving sacropelvic disorders, today announced that the company will be participating in the [...]
NovaBay Pharmaceuticals Announces One-Time Special Cash Dividend of $0.80 Per Share
26/08/2025
EMERYVILLE, Calif., Aug. 26, 2025 (GLOBE NEWSWIRE) -- NovaBay ® Pharmaceuticals, Inc. (NYSE American: NBY) (“NovaBay” or the “Company”) announces its Board of Directors and the Special Transaction Committee of the Board [...]
Sight Sciences to Present at the Upcoming Morgan Stanley Global Healthcare Conference
26/08/2025
MENLO PARK, Calif., Aug. 26, 2025 (GLOBE NEWSWIRE) -- Sight Sciences , Inc. (Nasdaq: SGHT) (Sight Sciences or the Company) an eyecare technology company focused on developing and commercializing innovative, [...]
Zentalis Pharmaceuticals Appoints James B. Bucher, JD, as Chief Legal Officer and Corporate Secretary
26/08/2025
Seasoned life sciences legal executive brings extensive public company experience, including broad strategic and financial transaction expertise SAN DIEGO, Aug. 26, 2025 (GLOBE NEWSWIRE) -- Zentalis ® Pharmaceuticals, [...]
IRADIMED CORPORATION to Participate in the 2025 Wells Fargo Healthcare Conference
26/08/2025
ORLANDO, Fla., Aug. 26, 2025 (GLOBE NEWSWIRE) -- IRADIMED CORPORATION (NASDAQ: IRMD), a leader in innovative medical devices for Magnetic Resonance Imaging (“MRI”) compatible patient monitoring and infusion systems, [...]
Immuneering Announces Closing of $25 Million Private Placement
26/08/2025
CAMBRIDGE, Mass., Aug. 26, 2025 (GLOBE NEWSWIRE) -- Immuneering Corporation (Nasdaq: IMRX), a clinical-stage oncology company focused on keeping cancer patients alive, today announced the closing of its previously [...]
iMDx to Participate in NYC Investment Conferences September 8 - 11
26/08/2025
NASHVILLE, Tenn., Aug. 26, 2025 (GLOBE NEWSWIRE) -- Insight Molecular Diagnostics Inc., or iMDx, (Nasdaq: IMDX), today announced participation in investor conferences hosted by both H.C. Wainwright and Lake Street [...]
Sana Biotechnology to Present at September 2025 Investor Conferences
26/08/2025
SEATTLE, Aug. 26, 2025 (GLOBE NEWSWIRE) -- Sana Biotechnology, Inc. (NASDAQ: SANA), a company focused on changing the possible for patients through engineered cells, today announced that it will webcast its [...]
Seer to Participate in the Morgan Stanley 23rd Annual Global Healthcare Conference
26/08/2025
REDWOOD CITY, Calif., Aug. 26, 2025 (GLOBE NEWSWIRE) -- Seer, Inc. (Nasdaq: SEER), the pioneer and trusted partner for deep, unbiased proteomic insights, today announced that the company will be participating in the [...]
Vera Therapeutics to Participate at Upcoming Investor Conferences
26/08/2025
BRISBANE, Calif., Aug. 26, 2025 (GLOBE NEWSWIRE) -- Vera Therapeutics, Inc. (Nasdaq: VERA), a late clinical-stage biotechnology company focused on developing and commercializing transformative treatments for patients [...]
LifeStance to Present at the 23rd Annual Morgan Stanley Healthcare Conference
26/08/2025
SCOTTSDALE, Ariz., Aug. 26, 2025 (GLOBE NEWSWIRE) -- LifeStance Health Group, Inc. (NASDAQ: LFST), one of the nation’s largest providers of outpatient mental health care, today announced that management will present at [...]
SRx Health Solutions Announces Receipt of Late Filing Notification Letter from NYSE American
26/08/2025
TAMPA, Fla., Aug. 26, 2025 (GLOBE NEWSWIRE) -- SRx Health Solutions, Inc. (NYSE American: SRXH) (the “Company”), a leading global health and wellness company, today announced that on August 20, 2025, it received an [...]
Inspire Medical Systems, Inc. Announces Departure of Chief Financial Officer
26/08/2025
MINNEAPOLIS, Aug. 26, 2025 (GLOBE NEWSWIRE) -- Inspire Medical Systems, Inc. (NYSE: INSP) (Inspire), a medical technology company focused on the development and commercialization of innovative, minimally invasive [...]
Dentsply Sirona to Participate in Upcoming Investor Conferences
26/08/2025
CHARLOTTE, N.C., Aug. 26, 2025 (GLOBE NEWSWIRE) -- DENTSPLY SIRONA Inc. (“Dentsply Sirona” or the "Company") (Nasdaq: XRAY) today announced its participation at upcoming conferences. Morgan Stanley 23 rd Annual Global [...]

Pages